TEST BANK For Applied Pharmacology for theDe
n n n n n n n
ntal Hygienist 9th Edition
n n n
by Elena Bablenis Haveles, Chapters 1 - 26 A+
n n n n n n n n
,Chapter 01: Information Sources, Regulatory Agencies, Drug Legislation, and PrescriptionWriting
n n n n n n n n n n
Haveles: Applied Pharmacology for the Dental Hygienist, 9th Edition
n n n n n n n n
MULTIPLEnCHOICE
1. Knowledgenofnpharmacologynaidsnthendentalnprofessionalnin
a. obtainingnanpatient’snhealthnhistory.
b. administeringndrugsninnthenoffice.
c. handlingnemergencynsituations.
d. selectionnofnannonprescriptionnmedication.
e. Allnofnthenabove.
ANSWER:n E
Allnofnthenchoicesnarentrue.nBecausenmanynofnournpatientsnarenbeingntreatednwithndrugs,nknowledgenofnph
armacologynhelpsninnunderstandingnandninterpretingnpatients’nresponsesntonhealthnhistorynquestions.nKno
wledgenofnthentherapeuticnandnadverseneffectsnofnmedicationsnobviouslynhelpsninntheirnpropernadministra
tionninnthenoffice.nEmergencynsituationsnmaynbencausednbyndrugsnorntreatednbyndrugs;nthus,nknowledgenof
npharmacologynisnofngreatnhelp,nespeciallynbecausenanrapidnresponsenisnsometimesnrequired.nAnclearnund
erstandingnofnthenconceptsnofndrugnaction,ndrugnhandlingnbynthenbody,nandndrugninteractionsnwillnallownt
hendentalnpractitionerntonmakenpropernjudgmentsnandngraspnthenconceptsnrelevantntonnewndrugntherapiesn
onnthenmarket.
DIF: Application
REF:n RolenofnthenDentalnHygienistn(Medication/HealthnHistory),nRolenofnthenDentalnHygienistn(MedicationnA
dministration),nRolenofnthenDentalnHygienistn(EmergencynSituations),nRolenofnthenDentalnHygienistn(Nonpre
scriptionnMedication)n|npp.n2-3 OBJ: 1
TOP:n NBDHE,n6.0.nPharmacology
2. Whichnofnthenfollowingnstatementsnisntruenregardingnplanningnappointments?
a. Whethernornnotnpatientsnarentakingnmedicationnfornsystemicndiseasesnisnofnlittle
consequenceninnthendentalnoffice.
b. Asthmaticnpatientsnshouldnhavendentalnappointmentsninnthenmorning.
c. Diabeticnpatientsnusuallynhavenfewernproblemsnwithnanmorningnappointment
comparednwithnafternoonnappointments.
d. BothnBnandnCnarentrue.
ANSWER:n D
Asthmaticnpatientsnwhonexperiencendentalnanxietynshouldnschedulentheirnappointmentsnwhenntheynarennot
nrushednornundernpressurenearlyninnthenmorning.nDiabeticnpatientsnusuallynhavenrelativelynfewernproblem
snwithnanmorningnappointment.nPatientsntakingnmedicationnfornsystemicndiseasesnmaynrequirenspecialnhan
dlingninnthendentalnoffice.
, DIF: Comprehension
REF:n RolenofnthenDentalnHygienistn(AppointmentnScheduling)n|np.n3n
OBJ:n 1 TOP:n NBDHE,n6.0.nPharmacology
3. Nutritionalnornherbalnsupplements
a. carrynthenU.S.nFoodnandnDrugnAdministrationn(FDA)napprovalnforndiseasenstates.
b. arennotndrugs.
c. canncausenadverseneffects.
d. willnnotninteractnwithnotherndrugsnthenpatientn maynbentaking.
ANSWER:n C
Nutritionalnornherbalnsupplementsnarenquitencapablenofncausingnadverseneffects.nThenmajoritynofnn
utritionalnornherbalnsupplementsndonnotncarrynFDAnapprovalnforntreatingndiseasenstates.nThesensu
pplementsnarendrugsnandncanncausenadverseneffectsnandninteractnwithndifferentndrugs.
DIF:n Comprehension
REF:nRolenofnthenDentalnHygienistn(NutritionalnornHerbalnSupplements)n|np.n3n
OBJ:n 1 TOP:n NBDHE,n6.0.nPharmacology
4. Whichntypenofndrugnnamenusuallynbeginsnwithnanlowercasen letter?
a. Brandnname
b. Codenname
c. Genericnname
d. Tradenname
ANSWER:n C
Beforenanyndrugnisnmarketed,nitnisngivennangenericnnamenthatnbecomesnthen“official”nnamenofnthendrug.nEa
chndrugnisnassignednonlynonengenericnnamenselectednbynthenU.S.nAdoptednNamenCouncil,nandnthennameni
snnotncapitalized.nThenbrandnnamenisnequivalentntonthentradennamenandnisncapitalized.nAlthoughnthenbrandn
namenisntechnicallynthennamenofnthencompanynmarketingnthenproduct,nthisntermnisnoftennusedninterchangea
blynwithnthentradenname.nThencodennamenisntheninitialntermnusednwithinnanpharmaceuticalncompanyntonrefe
rntonandrugnwhilenitnisnundergoingninvestigationnandnisnoftennancombinationnofncapitalnlettersnandnnumber
s,nthenlettersnrepresentingnannabbreviationnofnthencompanynname.
DIF: Comprehension
REF:n DrugnNamesn|np.n4nOBJ:n 3
TOP:n NBDHE,n6.0.nPharmacology
5. Andrug’sngenericnnamenisnselectednbynthe
a. pharmaceuticalncompanynmanufacturingnit.
b. FoodnandnDrugnAdministrationn(FDA).
c. U.S.nAdoptednNamenCouncil.
d. FederalnPatentnOffice.
, ANSWER:n C
Eachndrugnisnassignednonlynonengenericnnamen(e.g.,nibuprofen).nItnisnselectednbynthenU.S.nAdoptednName
nCouncil.nThengenericnnamenisnnotnselectednbynthenFDAnornthenFederalnPatentnOffice.nThenpharmaceutic
alncompanynmanufacturingnthendrugnclearlynhasnanninfluencenonnthengenericnnamengivennitsndrug,nbutnthenf
inalndecisionnisnnotnthencompany’s.
DIF: Recall REF:n DrugnNamesn|np.n4
OBJ:n 3nTOP:n NBDHE,n6.0.nPharmacology
6. Whichnofnthenfollowingnisntruenconcerningngenericnandntradennamesnofndrugs?
a. Andrugnmaynonlynhavenonengenericnnamenandnonentradenname.
b. Andrugnmaynonlynhavenonengenericnname,nbutn itnmaynhavenseveralntradennames.
c. Andrugnmaynhavenseveralngenericnnames,nbutnitn maynonlynhavenonentradenname.
d. Andrugnmaynhavenseveralngenericnnamesnandnseveralntradennames.
ANSWER:n B
Eachndrugnhasnonlynonengenericnnamenbutnmaynhavenseveralntradennames.nForneachndrug,ntherenisnonlynon
engenericnname.nItnisnnotncapitalized,nandnitnbecomesnthen“official”nnamenofnthendrug.nThenpharmaceutical
ncompanyndiscoveringnthendrugngivesnthendrugnantradenname.nThentradennamenisnprotectednbynthenFederaln
PatentnLawnforn20nyearsnfromnthenearliestnclaimednfilingndate,nplusnpatentntermnextensions.nAlthoughnthenb
randnnamenisntechnicallynthennamenofnthencompanynmarketingnthenproduct,nitnisnoftennusedninterchangeabl
ynwithnthentradenname.
DIF: Comprehension
REF:n DrugnNamesn|np.n4nOBJ:n 3
TOP:n NBDHE,n6.0.nPharmacology
7. Twondrugsnthatnarenfoundntonbenchemicallynequivalent,nbutnnotnbiologicallynequivalentnornt
herapeuticallynequivalentnarensaidntondiffernin
a. potency.
b. efficacy.
c. bioavailability.
d. therapeuticnindex.
ANSWER:n C
Anpreparationncannbenchemicallynequivalentnyetnnotnbiologicallynorntherapeuticallynequivalent.nThesenpr
oductsnarensaidntondifferninntheirnbioavailability.nThenpotencynofnandrugnisnanfunctionnofnthenamountnofndrug
nrequiredntonproducenanneffect.nThenefficacynisnthenmaximumnintensitynofneffectnornresponsenthatncannben
producednbynandrug.nThentherapeuticnindexnisnthenrationofnthenlethalndosenforn50%nofnthenexperimentalnan
imalsndividednbyntheneffectivendosenforn50%nofnthenexperimentalnanimals.nIfnthenvaluenofnthentherapeuticn
indexnisnsmall,ntoxicitynisnmorenlikely.
DIF: Recall
REF:n DrugnNamesn(DrugnSubstitution)n|np.n5nOBJ:n 4
TOP:n NBDHE,n6.0.nPharmacology
n n n n n n n
ntal Hygienist 9th Edition
n n n
by Elena Bablenis Haveles, Chapters 1 - 26 A+
n n n n n n n n
,Chapter 01: Information Sources, Regulatory Agencies, Drug Legislation, and PrescriptionWriting
n n n n n n n n n n
Haveles: Applied Pharmacology for the Dental Hygienist, 9th Edition
n n n n n n n n
MULTIPLEnCHOICE
1. Knowledgenofnpharmacologynaidsnthendentalnprofessionalnin
a. obtainingnanpatient’snhealthnhistory.
b. administeringndrugsninnthenoffice.
c. handlingnemergencynsituations.
d. selectionnofnannonprescriptionnmedication.
e. Allnofnthenabove.
ANSWER:n E
Allnofnthenchoicesnarentrue.nBecausenmanynofnournpatientsnarenbeingntreatednwithndrugs,nknowledgenofnph
armacologynhelpsninnunderstandingnandninterpretingnpatients’nresponsesntonhealthnhistorynquestions.nKno
wledgenofnthentherapeuticnandnadverseneffectsnofnmedicationsnobviouslynhelpsninntheirnpropernadministra
tionninnthenoffice.nEmergencynsituationsnmaynbencausednbyndrugsnorntreatednbyndrugs;nthus,nknowledgenof
npharmacologynisnofngreatnhelp,nespeciallynbecausenanrapidnresponsenisnsometimesnrequired.nAnclearnund
erstandingnofnthenconceptsnofndrugnaction,ndrugnhandlingnbynthenbody,nandndrugninteractionsnwillnallownt
hendentalnpractitionerntonmakenpropernjudgmentsnandngraspnthenconceptsnrelevantntonnewndrugntherapiesn
onnthenmarket.
DIF: Application
REF:n RolenofnthenDentalnHygienistn(Medication/HealthnHistory),nRolenofnthenDentalnHygienistn(MedicationnA
dministration),nRolenofnthenDentalnHygienistn(EmergencynSituations),nRolenofnthenDentalnHygienistn(Nonpre
scriptionnMedication)n|npp.n2-3 OBJ: 1
TOP:n NBDHE,n6.0.nPharmacology
2. Whichnofnthenfollowingnstatementsnisntruenregardingnplanningnappointments?
a. Whethernornnotnpatientsnarentakingnmedicationnfornsystemicndiseasesnisnofnlittle
consequenceninnthendentalnoffice.
b. Asthmaticnpatientsnshouldnhavendentalnappointmentsninnthenmorning.
c. Diabeticnpatientsnusuallynhavenfewernproblemsnwithnanmorningnappointment
comparednwithnafternoonnappointments.
d. BothnBnandnCnarentrue.
ANSWER:n D
Asthmaticnpatientsnwhonexperiencendentalnanxietynshouldnschedulentheirnappointmentsnwhenntheynarennot
nrushednornundernpressurenearlyninnthenmorning.nDiabeticnpatientsnusuallynhavenrelativelynfewernproblem
snwithnanmorningnappointment.nPatientsntakingnmedicationnfornsystemicndiseasesnmaynrequirenspecialnhan
dlingninnthendentalnoffice.
, DIF: Comprehension
REF:n RolenofnthenDentalnHygienistn(AppointmentnScheduling)n|np.n3n
OBJ:n 1 TOP:n NBDHE,n6.0.nPharmacology
3. Nutritionalnornherbalnsupplements
a. carrynthenU.S.nFoodnandnDrugnAdministrationn(FDA)napprovalnforndiseasenstates.
b. arennotndrugs.
c. canncausenadverseneffects.
d. willnnotninteractnwithnotherndrugsnthenpatientn maynbentaking.
ANSWER:n C
Nutritionalnornherbalnsupplementsnarenquitencapablenofncausingnadverseneffects.nThenmajoritynofnn
utritionalnornherbalnsupplementsndonnotncarrynFDAnapprovalnforntreatingndiseasenstates.nThesensu
pplementsnarendrugsnandncanncausenadverseneffectsnandninteractnwithndifferentndrugs.
DIF:n Comprehension
REF:nRolenofnthenDentalnHygienistn(NutritionalnornHerbalnSupplements)n|np.n3n
OBJ:n 1 TOP:n NBDHE,n6.0.nPharmacology
4. Whichntypenofndrugnnamenusuallynbeginsnwithnanlowercasen letter?
a. Brandnname
b. Codenname
c. Genericnname
d. Tradenname
ANSWER:n C
Beforenanyndrugnisnmarketed,nitnisngivennangenericnnamenthatnbecomesnthen“official”nnamenofnthendrug.nEa
chndrugnisnassignednonlynonengenericnnamenselectednbynthenU.S.nAdoptednNamenCouncil,nandnthennameni
snnotncapitalized.nThenbrandnnamenisnequivalentntonthentradennamenandnisncapitalized.nAlthoughnthenbrandn
namenisntechnicallynthennamenofnthencompanynmarketingnthenproduct,nthisntermnisnoftennusedninterchangea
blynwithnthentradenname.nThencodennamenisntheninitialntermnusednwithinnanpharmaceuticalncompanyntonrefe
rntonandrugnwhilenitnisnundergoingninvestigationnandnisnoftennancombinationnofncapitalnlettersnandnnumber
s,nthenlettersnrepresentingnannabbreviationnofnthencompanynname.
DIF: Comprehension
REF:n DrugnNamesn|np.n4nOBJ:n 3
TOP:n NBDHE,n6.0.nPharmacology
5. Andrug’sngenericnnamenisnselectednbynthe
a. pharmaceuticalncompanynmanufacturingnit.
b. FoodnandnDrugnAdministrationn(FDA).
c. U.S.nAdoptednNamenCouncil.
d. FederalnPatentnOffice.
, ANSWER:n C
Eachndrugnisnassignednonlynonengenericnnamen(e.g.,nibuprofen).nItnisnselectednbynthenU.S.nAdoptednName
nCouncil.nThengenericnnamenisnnotnselectednbynthenFDAnornthenFederalnPatentnOffice.nThenpharmaceutic
alncompanynmanufacturingnthendrugnclearlynhasnanninfluencenonnthengenericnnamengivennitsndrug,nbutnthenf
inalndecisionnisnnotnthencompany’s.
DIF: Recall REF:n DrugnNamesn|np.n4
OBJ:n 3nTOP:n NBDHE,n6.0.nPharmacology
6. Whichnofnthenfollowingnisntruenconcerningngenericnandntradennamesnofndrugs?
a. Andrugnmaynonlynhavenonengenericnnamenandnonentradenname.
b. Andrugnmaynonlynhavenonengenericnname,nbutn itnmaynhavenseveralntradennames.
c. Andrugnmaynhavenseveralngenericnnames,nbutnitn maynonlynhavenonentradenname.
d. Andrugnmaynhavenseveralngenericnnamesnandnseveralntradennames.
ANSWER:n B
Eachndrugnhasnonlynonengenericnnamenbutnmaynhavenseveralntradennames.nForneachndrug,ntherenisnonlynon
engenericnname.nItnisnnotncapitalized,nandnitnbecomesnthen“official”nnamenofnthendrug.nThenpharmaceutical
ncompanyndiscoveringnthendrugngivesnthendrugnantradenname.nThentradennamenisnprotectednbynthenFederaln
PatentnLawnforn20nyearsnfromnthenearliestnclaimednfilingndate,nplusnpatentntermnextensions.nAlthoughnthenb
randnnamenisntechnicallynthennamenofnthencompanynmarketingnthenproduct,nitnisnoftennusedninterchangeabl
ynwithnthentradenname.
DIF: Comprehension
REF:n DrugnNamesn|np.n4nOBJ:n 3
TOP:n NBDHE,n6.0.nPharmacology
7. Twondrugsnthatnarenfoundntonbenchemicallynequivalent,nbutnnotnbiologicallynequivalentnornt
herapeuticallynequivalentnarensaidntondiffernin
a. potency.
b. efficacy.
c. bioavailability.
d. therapeuticnindex.
ANSWER:n C
Anpreparationncannbenchemicallynequivalentnyetnnotnbiologicallynorntherapeuticallynequivalent.nThesenpr
oductsnarensaidntondifferninntheirnbioavailability.nThenpotencynofnandrugnisnanfunctionnofnthenamountnofndrug
nrequiredntonproducenanneffect.nThenefficacynisnthenmaximumnintensitynofneffectnornresponsenthatncannben
producednbynandrug.nThentherapeuticnindexnisnthenrationofnthenlethalndosenforn50%nofnthenexperimentalnan
imalsndividednbyntheneffectivendosenforn50%nofnthenexperimentalnanimals.nIfnthenvaluenofnthentherapeuticn
indexnisnsmall,ntoxicitynisnmorenlikely.
DIF: Recall
REF:n DrugnNamesn(DrugnSubstitution)n|np.n5nOBJ:n 4
TOP:n NBDHE,n6.0.nPharmacology
